Fatigue in early multiple sclerosis: MRI metrics of neuroinflammation, relapse and neurodegeneration.
fatigue
magnetic resonance imaging
multiple sclerosis
neurodegeneration
neuroinflammation
Journal
Brain communications
ISSN: 2632-1297
Titre abrégé: Brain Commun
Pays: England
ID NLM: 101755125
Informations de publication
Date de publication:
2024
2024
Historique:
received:
22
02
2024
revised:
27
05
2024
accepted:
13
08
2024
medline:
10
10
2024
pubmed:
10
10
2024
entrez:
10
10
2024
Statut:
epublish
Résumé
Multiple sclerosis (MS) is a neuroinflammatory and neurodegenerative disease affecting the brain and spinal cord. Fatigue is a common disabling symptom from MS onset, however the mechanisms by which underlying disease processes cause fatigue remain unclear. Improved pathophysiological understanding offers potential for improved treatments for MS-related fatigue. MRI provides insights into
Identifiants
pubmed: 39386090
doi: 10.1093/braincomms/fcae278
pii: fcae278
pmc: PMC11462441
doi:
Types de publication
Journal Article
Langues
eng
Pagination
fcae278Informations de copyright
© The Author(s) 2024. Published by Oxford University Press on behalf of the Guarantors of Brain.
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest relevant to this paper. D.S.R. received research support from companies Abata Therapeutics, Sanofi-Genzyme and Vertex Pharmaceuticals, unrelated to this paper.